EMA Authorised: Humalog (insulin lispro) — Eli Lilly Nederland B.V.

View source ↗

Summary

The European Medicines Agency authorised Humalog (insulin lispro) for the treatment of diabetes mellitus. The marketing authorisation holder is Eli Lilly Nederl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Humalog (insulin lispro)

Snippet

Status: Authorised. Therapeutic area: Diabetes Mellitus. MAH: Eli Lilly Nederland B.V.. Decision date: 21/01/2026